Continuous Infusion and Intermittent Bolus Adductor Canal Block for Total Knee Arthroplasty

Launched by NATIONAL CHENG-KUNG UNIVERSITY HOSPITAL · Aug 24, 2022

Keywords

ClinConnect Summary

This clinical trial is studying a method to help manage pain for patients undergoing total knee replacement surgery. Specifically, researchers want to see if using a continuous infusion of local anesthetics combined with shorter doses, called boluses, can better control pain compared to longer doses. The goal is to reduce pain levels and the amount of opioid medication needed after surgery.

To participate in this trial, you should be an adult planning to have a knee replacement surgery while under spinal anesthesia. You would also need to be healthy enough to cooperate during the study and not have certain conditions like allergies to the study medications, chronic pain, or neuromuscular diseases. If you choose to participate, you can expect to receive either the continuous infusion and bolus treatment or a different approach, and your pain levels and medication use will be closely monitored during your recovery.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Adults receiving unilateral total knee arthroplasty under spinal anesthesia
• • American society of anesthesiologists 1-3
• Exclusion Criteria:
• • Could not cooperate
• • Allergy to medicines used in the study
• • Chronic pain
• • Long term opioid use
• • Neuromuscular disease
• • Surgical complication: massive bleeding, postoperative ICU, unanticipated procedure